Custom Search

News

Saturday 01 January 2005

Rituximab in primary conjunctiva lymphoma.

By: Zinzani PL, Alinari L, Stefoni V, Loffredo A, Pichierri P, Polito E.

Leuk Res 2005 Jan;29(1):107-8

Our experience with a patient with a primary conjunctiva lymphoma who was treated with conventional dose of rituximab obtaining a complete response without acute and late local toxicity for the eye.

Use of this site is subject to the following terms of use